Unlike neglected tropical diseases, NCDs threaten low-, middle-, and high-income countries and consequently there are large markets and powerful incentives for research and development into drugs, vaccines, and diagnostics for common NCDs. However, these technologies may not always be appropriate in developing countries. For example, insulin, which is commonly used to treat diabetes, requires refrigeration, which has limited availability amongst households in resource-poor settings.
We developed this survey as a precursor to a larger study that will landscape research and development (R&D) needs for NCDs in developing countries. The aim of the overall work is to determine whether the development of new drugs, vaccines, and diagnostics for the special needs of developing countries could have a substantial impact in reducing the burden of NCDs in low- and middle-income countries. Your input is greatly valued!